Chinese Journal of Pharmaceuticals
|
2022, 53(2): 277-282
• Pharmaceutical Management & Information •
Introduction and Analysis of US FDA"Product-specific Guidances for Generic Drug Development" of Topical Drugs
Full
Affiliations
- Chongqing Huapont Pharm Co., Ltd., Chongqing 401121
Published: 2022-02-10
doi: 10.16522/j.cnki.cjph.2022.02.016
Outline
陈振.
美国FDA《仿制药开发的个药指导原则》中局部外用药的生物等效性评价方法介绍和分析.
中国医药工业杂志,
2022
, 53
(2)
: 277
-282
.
DOI: 10.16522/j.cnki.cjph.2022.02.016
Zhen CHEN.
Introduction and Analysis of US FDA"Product-specific Guidances for Generic Drug Development" of Topical Drugs[J].
Chinese Journal of Pharmaceuticals,
2022
, 53
(2)
: 277
-282
.
DOI: 10.16522/j.cnki.cjph.2022.02.016
Year 2022 volume 53 Issue 2
83
14
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2022.02.016
- Receive Date:2021-09-23
- Online Date:2026-11-12
- Published:2022-02-10